Management

Executive Management Board

Dr. Sven K. Weber
Dr. Sven K. Weber
Chief Executive Officer (CEO) BRAIN Biotech AG
Dr. Sven K. Weber
Chief Executive Officer (CEO) BRAIN Biotech AG
  • Year of birth: 1982
  • Nationality: German
  • Appointment: since October 1, 2026; appointed until September 30, 2029

Dr. Sven K. Weber is an internationally experienced manager with proven expertise in the industrial enzyme business. Since 2011 he has held various leadership positions within the BASF Group, most recently heading its global enzyme business. As Vice President, Dr. Weber was responsible for the global business unit Feed Enzymes & Feed Performance Ingredients of the BASF Group. In this role he consistently aligned the business towards innovation-driven profitable growth and significantly increased sales and earnings. Prior to that, he led the worldwide automotive OEM business of Chemetall GmbH, at the time part of the BASF Group, as Global Segment Director. At hte GmbH in Heidelberg, a leading provider of high-throughput solutions for R&D workflows, he headed contract research. Dr. Weber began his professional career at the Merck Group in Darmstadt.

Dr. Sven K. Weber holds a degree in chemistry (Diplom-Chemiker) from the University of Wuppertal and obtained his doctorate at Heidelberg University. He additionally completed an executive programme in general management at the SGMI Management Institute St. Gallen, focusing on strategy, corporate management and finance.

Dr. Sven K. Weber was appointed to the Management Board of BRAIN Biotech AG as Chief Executive Officer with effect from October 1, 2026.

Dr. Sven K. Weber
Michael Schneiders
Michael Schneiders
Chief Financial Officer (CFO) BRAIN Biotech AG
Michael Schneiders
Chief Financial Officer (CFO) BRAIN Biotech AG
  • Year of birth: 1970
  • Nationality: Deutsch
  • Appointment: since October 1, 2022; appointed until September 30, 2029

Michael Schneiders has more than twenty years of experience in the capital market with a strong focus on German equities and international institutional investors. Prior to his employment at BRAIN, Michael held a variety of management positions in investment banking, including Head of Equities & Research. He was also involved in the IPO of BRAIN.

Michael studied Business Administration with a focus on finance and marketing at the University of Siegen, Germany, and Economics at the University of Redlands, US. In addition, he completed several executive education modules in the US at the Kellogg School of Management and the University of Chicago.

In Mai 2020, Michael joined former BRAIN AG as Head of Investor Relations and later became, in addition, the Head of Sustainability. BRAIN Biotech AG appointed Michael Schneiders as Chief Financial Officer (CFO) to the executive management board effective from October 1, 2022.

Michael Schneiders

Management

Johan Jansén-Storbacka
Johan Jansén-Storbacka
EVP, Enzyme Products
Johan Jansén-Storbacka
EVP, Enzyme Products

Johan Jansén-Storbacka serves as Executive Vice President of the BRAINBiocatalysts´ enzyme products business where he will drive the BRAIN Biotech Group’s strategy to strengthen its enzyme and fermentation business.

Education

  • MBA, IMD Business School, Switzerland (2009)
  • Engineering & Management, KTH Royal Institute of Technology, Sweden (1995–2001)

Career Highlights

  • BRAIN Biotech (September 1, 2025 - present): Executive Vice President of the BRAINBiocatalysts Enzyme Products business
  • IFF (2021 – 2025): Business Director Personal Care Ingredients
  • DuPont Nutrition & Biosciences (2010 – 2021): Held senior roles including Global Business Director and Global Marketing Director, steering innovations in industrial biosciences, personal care, and animal nutrition
  • Whirlpool (2002 – 2008): Held various European management positions in supply chain, sales operations, and customer service

LinkedIn

Johan Jansén-Storbacka
Daren Bryce
Daren Bryce
VP Life Science & Fermentation Solutions
Daren Bryce
VP Life Science & Fermentation Solutions

Location site BRAINBiocatalysts in Cardiff, Wales, UK:
Biocatalysts Ltd.
Unit 1, Cefn Coed,
Parc Nantgarw,
Cardiff CF15 7QQ
Wales, UK

LinkedIn

Daren Bryce
Dr. Andrew Ellis
Dr. Andrew Ellis
VP Fermentation & Technical
Dr. Andrew Ellis
VP Fermentation & Technical

Location site BRAINBiocatalysts in Cardiff, Wales, UK:
Biocatalysts Ltd.
Unit 1, Cefn Coed,
Parc Nantgarw,
Cardiff CF15 7QQ
Wales, UK

LinkedIn

Dr. Andrew Ellis
Dr. Ludwig Klermund
Dr. Ludwig Klermund
VP Products North America
Dr. Ludwig Klermund
VP Products North America

Location site Biocatalysts North America:
Biocatalysts Inc
6306 Benjamin Rd, Ste 600
Tampa, FL 33634, USA

P: 813-888-9855
inquiries-us(at)biocatalysts.com

LinkedIn

 

Dr. Ludwig Klermund
Dr. Martin Langer
Dr. Martin Langer
EVP, MD Operations Zwingenberg, Business Development
Dr. Martin Langer
EVP, MD Operations Zwingenberg, Business Development

Location site BRAINBiocatalysts Zwingenberg:
BRAIN Biotech AG
Darmstädter Straße 34 - 36
64673 Zwingenberg
Germany
Website BRAIN Biotech Zwingenberg

LinkedIn

Dr. Martin Langer
Dr. Lutz Müller-Kuhrt
Dr. Lutz Müller-Kuhrt
MD AnalytiCon Discovery
Dr. Lutz Müller-Kuhrt
MD AnalytiCon Discovery

Location site AnalytiCon Discovery (a branch site of BRAIN Biotech AG):
Hermannswerder Haus 17
14473 Potsdam
Germany

Website

LinkedIn

Dr. Lutz Müller-Kuhrt
Dr. Alexander Pelzer
Dr. Alexander Pelzer
VP, Head of R&D Zwingenberg
Dr. Alexander Pelzer
VP, Head of R&D Zwingenberg

Location site BRAINBiocatalysts in Zwingenberg, Germany:
BRAIN Biotech AG
Darmstädter Straße 34 – 36
64673 Zwingenberg
Deutschland

Kontakt

LinkedIn

Dr. Alexander Pelzer